| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/RCCM.200405-681OC |
| P698 | PubMed publication ID | 15306533 |
| P50 | author | Rakesh K. Kumar | Q52699920 |
| P2093 | author name string | Paul S Foster | |
| Lily Li | |||
| Cristan Herbert | |||
| Dianne C Webb | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 1043-1048 | |
| P577 | publication date | 2004-08-11 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Effects of anticytokine therapy in a mouse model of chronic asthma | |
| P478 | volume | 170 |
| Q36701411 | A Cell-Impermeable Cyclosporine A Derivative Reduces Pathology in a Mouse Model of Allergic Lung Inflammation |
| Q37012219 | A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production |
| Q45399694 | A potential immunotherapy approach: mucosal immunization with an IL-13 peptide-based virus-like particle vaccine in a mouse asthma model |
| Q30540980 | Absence of alpha 4 but not beta 2 integrins restrains development of chronic allergic asthma using mouse genetic models |
| Q35631650 | Additive anti-allergic effects of anti-interleukin-33 and anti-Siglec-F treatments in a murine model of allergic asthma |
| Q37038081 | Airway smooth muscle cell as an inflammatory cell: lessons learned from interferon signaling pathways |
| Q37237665 | Airways inflammation and treatment during acute exacerbations of COPD. |
| Q36062733 | Allergen-induced airway remodelling |
| Q36080147 | Allergic rhinitis, asthma, airway biology, and chronic obstructive pulmonary disease in AJRCCM in 2004. |
| Q28652444 | Ambient particulate matter induces an exacerbation of airway inflammation in experimental asthma: role of interleukin-33 |
| Q34119421 | Anisakis pegreffii-induced airway hyperresponsiveness is mediated by gamma interferon in the absence of interleukin-4 receptor alpha responsiveness |
| Q36282984 | Are mouse models of asthma appropriate for investigating the pathogenesis of airway hyper-responsiveness? |
| Q38528048 | Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies |
| Q53368128 | Beneficial effect of anti-interleukin-33 on the murine model of allergic inflammation of the lower airway. |
| Q36062587 | Building better mouse models of asthma |
| Q34073570 | Chronic inflammation and asthma |
| Q37196833 | Combined sensitization of mice to extracts of dust mite, ragweed, and Aspergillus species breaks through tolerance and establishes chronic features of asthma |
| Q34903133 | Cytokine/anti-cytokine therapy - novel treatments for asthma? |
| Q37405187 | Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin |
| Q46496990 | Efficacy of macrophage-activating lipopeptide-2 combined with interferon-gamma in a murine asthma model. |
| Q53304689 | Eosinophils Are Dispensable for Allergic Remodeling and Immunity in a Model of House Dust Mite–induced Airway Disease |
| Q35569863 | Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling |
| Q36981836 | Epigenetic changes associated with disease progression in a mouse model of childhood allergic asthma |
| Q43710718 | Evaluation of Th17-related cytokines and IFNγ production from blood mononuclear cells of moderate and severe asthmatic children reveals methylprednisolone does not decrease IL-22 levels |
| Q51983885 | Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells. |
| Q37562266 | Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production |
| Q54421098 | IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. |
| Q34857748 | IL-4-mediated fine tuning of IL-12p70 production by human DC. |
| Q45324390 | Identification of IFN-γ and IL-27 as Critical Regulators of Respiratory Syncytial Virus-Induced Exacerbation of Allergic Airways Disease in a Mouse Model. |
| Q81470399 | Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae |
| Q82123821 | Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model |
| Q42181941 | Interleukin-33 drives activation of alveolar macrophages and airway inflammation in a mouse model of acute exacerbation of chronic asthma |
| Q36942008 | Invasive and noninvasive methods for studying pulmonary function in mice. |
| Q36383158 | Low doses of exogenous interferon-γ attenuated airway inflammation through enhancing Fas/FasL-induced CD4+ T cell apoptosis in a mouse asthma model |
| Q37173306 | Mechanisms in allergic airway inflammation - lessons from studies in the mouse |
| Q39402859 | Modeling TH 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma |
| Q37353895 | Mouse models of allergic asthma: acute and chronic allergen challenge |
| Q39237092 | Mouse models of severe asthma: Understanding the mechanisms of steroid resistance, tissue remodelling and disease exacerbation |
| Q47246192 | Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma |
| Q37859521 | Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. |
| Q41433501 | Non-Clinical Pharmacokinetics, Prediction of Human Pharmacokinetics and First-in-Human Dose Selection for CNTO 5825, an Anti-Interleukin-13 Monoclonal Antibody |
| Q33836175 | Outcome of occupational asthma after removal from exposure: A follow-up study |
| Q47767965 | Penh is not a validated technique for measuring airway function in mice |
| Q79764631 | Pharmacokinetic and pharmacodynamic modeling of a humanized anti-IL-13 antibody in naive and Ascaris-challenged cynomolgus monkeys |
| Q35570946 | Polymorphisms associated with asthma are inversely related to glioblastoma multiforme |
| Q92879746 | Potential Mechanisms of T Cell-Mediated and Eosinophil-Independent Bronchial Hyperresponsiveness |
| Q53779331 | Preclinical Safety and Pharmacology of an Anti-Human Interleukin-13 Monoclonal Antibody in Normal Macaques and in Macaques with Allergic Asthma |
| Q37098568 | RANTES (CCL5) regulates airway responsiveness after repeated allergen challenge |
| Q33318473 | Reduced lung function in a chronic asthma model is associated with prolonged inflammation, but independent of peribronchial fibrosis |
| Q35787045 | Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. |
| Q35504266 | Responses of airway epithelium to environmental injury: role in the induction phase of childhood asthma |
| Q52934058 | Role of local pulmonary IFN-gamma expression in murine allergic airway inflammation. |
| Q79197074 | Roles of CD4+CD25+ T cells in the development of experimental murine allergic conjunctivitis |
| Q36699742 | Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma |
| Q33321672 | Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma |
| Q41969902 | T-bet is induced by interferon-γ to mediate chemokine secretion and migration in human airway smooth muscle cells |
| Q37056577 | Targeting eosinophils in asthma |
| Q34519468 | Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling |
| Q38057796 | Th2 cytokine antagonists: potential treatments for severe asthma |
| Q92187895 | The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma |
Search more.